Skip to content

Clinical trials

Observational Polycystic Ovary Syndrome trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polycystic Ovary Syndrome Phase: Observational Country / region: China Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20164
20181
20192
20201
20213
20221
20231
20241
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9
Completed4
Recruiting4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Guangdong Women and Children Hospital3
RenJi Hospital3
Shanghai 10th People's Hospital2
Bing He1
Fudan University1
Fujian Maternity and Child Health Hospital1
Gui Xiaoting1
Heilongjiang University of Chinese Medicine1
Peking University Third Hospital1
Shandong University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polycystic Ovary Syndrome19
Insulin Resistance4
Diabetes, Gestational1
Obesity1
Pregnancy Complications1
Thrombophilia1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.